Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Dias Lourenço (Sao Paulo, Brazil), L. Emidio De França Silva (Sao Paulo, Brazil), I. Santos De Genaro (Sao Paulo, Brazil), J. Ito (Sao Paulo, Brazil), A. Pietrobon (Sao Paulo, Brazil), M. Notomi Sato (Sao Paulo, Brazil), J. Gross (Sao Paulo, Brazil), E. Negri (Sao Paulo, Brazil), D. Frediani Barbeiro (Sao Paulo, Brazil), W. Paganelli Rosolia Teodoro (Sao Paulo, Brazil), J. De Miranda (Sao Paulo, Brazil), B. Mangueira Saraiva-Romanholo (Sao Paulo, Brazil), R. De Paula Vieira (Sao Paulo, Brazil), F. Degobbi Tenorio Quirino Dos Santos Lopes (Sao Paulo, Brazil). Intracellular mechanisms of Th17/Treg differentiation in mild and moderate COPD patients. 3340

Member's Comments

No comment yet.

Related content which might interest you: Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002 Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Redox systems of neutrophils of patients with exacerbated COPD Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 The potential mechanism of Th17/Treg imbalance in the microenvironments of chronic inflammation and allergic asthma Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Cytokine regulation of local and systemic inflammation in COPD patients Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 T regulatory cells in exacerbation control of chronic obstructive pulmonary disease of mild and moderate stage Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Catabolic/anabolic balance in patients with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004